Drug delivery technologies: The way forward in the new decade

Industrial and Engineering Chemistry Research

Volumn 48, Issue 5, 2009, Pages 2475-2486

  Del Valle, Eva M Martin ^a   Galán, Miguel A ^a   Carbonell, Ruben G ^b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b North Carolina State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL BARRIERS; BIOLOGICAL ENVIRONMENTS; BIOPHARMACEUTICALS; CELLULAR LEVELS; DELIVERY SYSTEMS; DESIGN AND DEVELOPMENT; DRUG DELIVERY SYSTEMS; ENGINEERING SCIENCE; MULTI-DISCIPLINARY TEAMS; NOVEL MATERIALS; PHYSICO-CHEMICAL PROPERTIES;

CELL MEMBRANES; DRUG DELIVERY; MACROMOLECULES; SUPRAMOLECULAR CHEMISTRY;

BIOLOGICAL MATERIALS;

EID: 65349177235     PISSN: 08885885     EISSN: None     Source Type: Journal    
DOI: 10.1021/ie800886m     Document Type: Article

References (103)

1. Park, K. Controlled Drug Delivery: Challenges and Strategies; American Chemical Society: Washington, DC, 1997.
2. Park, K.; Marshy, R. Controlled Drug Delivery: Designing Technologies for the Future; ACS Symposium Series 752; American Chemical Society: Washington, DC. 2000.
3. Breimer, D. D. Future Changes for Drug Delivery. J. Controlled Release 1999, 62 (1-2), 3-6.
4. Juliano, R. L. Controlled Delivery of drugs: and oVerview and prospectus 1980; Oxford University Press: New York, 1990.
5. Klausner, E. A.; Lavi, E.; Friedman, M.; Hoffman, A. Novel levodopa gastroretentive dosage form: in-vivo evaluation in dogs. J. Controll. Rel. 2003, 88 (1), 117-126.
6. National Science and Technology Council Committee on Technology. The National Nanotechnology Initiative: research and Development leading to a Revolution in technology and industry, Office of Science and Technology Policy, Washington, D.C., 2005.
7. Brayden, D. J. Controlled release technologies for drug Delivery. Drug Discovery Today 2003, 8, 976-978.
8. Hughes, G. A. Nanostructure-mediated drug Delivery. Nanomedicine 2005, 1, 22-30.
9. Drummond, D. C.; Meyer, O.; Hong, K.; Kirpotin, D. B.; Papahadjopoulos, D. Optimizing liposomes for Delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 1999, 51, 691-743.
10. Au, J. L.; Jang, S. H.; Zheng, J.; Chen, C. T.; Song, S.; Hu, L. Determinants of drug Delivery and transport to solid tumors. J. Controlled Release 2001, 74, 31-46.
11. Fetterly, G. J.; Straubinger, R. M. Pharmacokinetics of paclitaxelcontaining liposomes in rats. AAPS Pharm. Sci. 2003, 5, E32.
12. Hoarau, D.; Delmas, P.; David, S.; Roux, E.; Leroux, J. C. Novel long-circulating lipid nanocapsules. Pharm. Res. 2004, 21, 1783-1789.
13. Moghimi, S. M.; Szebeni, J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and proteinbinding properties. Prog. Lipid Res. 2003, 42, 463-478.
14. Koo, O.; Rubinstein, I.; Onyuksel, H. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine. Nanomedicine 2005, 1, 77-84.
15. Kristl, J.; Volk, B.; Gasperlin, M.; Sentjurc, M.; Jurkovic, P. Effect of colloidal carriers on ascorbyl palmitate stability. Eur. J. Pharm. Sci. 2003, 19, 181-189.
16. Arnedo, A.; Irache, J. M.; Merodio, M.; Espuelas, M.; Millan, S. Albumin nanoparticles improved the stability, nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotide. J. Controlled Release 2004, 94, 217-227.
17. Lin, C. C.; Metters, A. T. Hydrogels in controlled release formulations: network design and mathematical modeling. AdV. Drug. Del. Rev. 2006, 58, 1379-1408.
18. Papadopoulou, V.; Kosmidis, K.; Vlachou, M.; Macheras, P. On the use of the weibull function for the discernment of drug release mechanisms. Int. J. Pharm. 2006, 309, 44-50.
19. Bose, S.; Bogner, R. H. Solventless pharmaceutical coating processes: a Review. Pharm. Dev. Technol. 2007, 12, 115-131.
20. Strübing, S.; Metz, H.; Mäder, K. Mechanistic analysis of drug release from tablets with membrane controlled drug Delivery. Eur. J. Pharm. Biopharm. 2007, 66, 113-119.
21. Lecomte, F.; Siepmann, J.; Walther, M.; MacRae, R. J.; Bodmeier, R. pH-sensitive polymer blends used as coating materials to control drug release from spherical beads: elucidation of the underlying mass transport mechanisms. Pharm. Res. 2005, 22, 1129-1141.
22. Acharya, G.; Park, K. Mechanisms of controlled drug release from drug-eluting stents. AdV. Drug Delivery Rev. 2006, 58, 387-401.
23. Kramar, A.; Turk, S.; Vrecer, F. Statistical optimization of diclofenac sustained release pellets coated with polymethacrylic films. Int. J. Pharm. 2003, 256, 43-52.
24. Chan, L. W.; Ong, K. T.; Heng, P. W. Novel film modifiers to alter the physical properties of composite ethylcellulose films. Pharm. Res. 2005, 22, 476-489.
25. Eaimtrakarn, S.; Prasad, Y. V. R.; Puthli, S. P.; Yoshikawa, Y.; Shibata, N.; Takada, K. Possibility of a patch system as a new oral Delivery system. Int. J. Pharm. 2003, 250, 111-117.
26. Whitehead, K. Z.; Shen, S.; Mitragotri, S. Oral Delivery of macromolecules using intestinal patches: applications for insulin Delivery. J. Controlled Release 2004, 98, 37-45.
27. Carino, G. P.; Jacob, J. S.; Mathiowitz, E. Nanosphere based oral insulin Delivery. J. Controlled Release 2000, 65, 261-269.
28. Kidron, M.; Dinh, S.; Menachem, Y.; Abbas, R.; Variano, B.; Goldberg, M.; Arbit, E.; Bar-On, H. A novel per-oral insulin formulation: proof of concept study in non-diabetic subjects. Diabet. Med 2004, 21, 354- 357.
29. Martin, F. J.; Grove, C. Microfabricated drug Delivery systems: concepts to improve clinical benefit. Biomed. MicroDevices 2001, 3, 97- 108.
30. Foraker, A. B.; Walczak, R. J.; Cohen, M. H.; Boiarski, T. A.; Grove, C. F.; Swaan, P. W. Microfabricated porous silicon particles enhance paracellular Delivery of insulin across intestinal Caco-2 cell monolayers. Pharm. Res. 2003, 20, 110-116.
31. Cohen, M. H. Microfabrication of silicon-based nanoporous particulates for medical applications. Biomed. MicroDevices 2003, 5, 253- 259.
32. Tao, S. L.; Lubeley, M. W.; Desai, T. A. Bioadhesive poly(methyl methacrylate) microDevices for controlled drug Delivery. J. Controlled Release 2003, 88, 215-228.
33. Chan, H. Dry powder aerosol drug Deliverysopportunities for colloid and surface scientists. Colloids Surf. A: Physicochem. Eng. Aspects 2006, 284-285, 50-55.
34. Chow, A. H. L.; Tong, H. H. Y.; Chattopadhyay, P.; Shekunov, B. Y. Particle engineering for pulmonary drug Delivery. Pharm. Res. 2007, 24 (3), 411-437.
35. Coates, M. S.; Chan, H. K.; Fletcher, D. F.; Chiou, H. Influence of mouthpiece geometry on the aerosol Delivery performance of a dry powder inhaler. Pharm. Res. 2007, 24 (8), 1450-1456.
36. Daniher, D. I.; Zhu, J. Dry powder platform for pulmonary drug Delivery. Particuology 2008, 6 (4), 225-238.
37. Edwards, D. A.; Hanes, J.; Caponetti, G.; Hrkach, J.; Ben-Jebria, A.; Eskew, M. L.; Mintzes, J.; Deaver, D.; Lotan, N.; Langer, R. Large porous particles for pulmonary drug Delivery. Science 1868, 576 (1997), 1871.
38. Foss, A. C.; Goto, T.; M. Morishita, N. A. Peppas Development of acrylic-based copolymers for oral insulin Delivery. Eur. J. Pharm. Biopharm. 2004, 57, 163-169.
39. Langer, R.; Peppas, N. A. Advances in Biomaterials, Drug Delivery, and Bionanotechnology. AIChE J. 2003, 49 (12), 2990-3006.
40. Guy, R. H.; Hadgraft, J.; Bucks, D. A. Transdermal drug Delivery and cutaneous metabolism. Xenobiotica 1987, 17, 325-343.
41. Prausnitz, M. R.; Mitragotri, S.; Langer, R. Current status and future potential of transdermal drug Delivery. Nat. Rev. Drug Discov. 2004, 3, 115-124.
42. Bellhouse, B. J. Kendall, M. A. F. Modified-Release Drug Delivery Technology: Marcel Dekker: New York, 2003.
43. Mehier-Humbert, S.; Guy, R. H. Physical methods for gene transfer: improving the kinetics of gene Delivery into cells. Adv. Drug Delivery Rev. 2005, 57, 733-753.
44. Kim, B. Y.; Doh, H. J.; Le, T. Y.; Cho, W. J.; Yong, C. S.; Choi, H. G.; Kim, J. S.; Lee, C. H.; Kim, D. D. Ketorolac amid prod rugs for transdermal Delivery: stability and in vitro rat skin permeation studies. Int. J. Pharm. 2005, 293, 193-202.
45. Chairello, K. Breaking the barrier. Advances in transdermal technology. Pharm. Technol. 2004, 46-56.
46. Ramakrishna, S.; Mayer, J.; Wintermantel, E.; Leong, K. W. Biomedical applications of polymer-composite materials: a Review. Composite Sci. Technol. 2001, 61, 1189-1224.
47. Mestiri, M.; Benoit, J. P.; Hernigou, P.; Devissaguet, J. P.; Puisieux, F. Cisplatin-loaded poly(methyl methacrylate) implants: a sustained drug Delivery system. J. Controlled Release 1995, 33, 107-113.
48. Hughes, L. G.; Vick, T. A.; Wang, J. H. Coated Implants. European Patent 1250164, 2004.
49. Szymura-Oleksiak, J.; Slosarczyk, A.; Cios, A.; Mycek, B.; Paszkiewicz, Z.; Szklarczyk, S.; Stankiewicz, D. The kinetics of pentoxifylline release in vivo from drug-loaded hydroxyapatite implants. Ceram. Int. 2001, 27, 767-772.
50. Lee, J. C.; Pushpala, S.; Lee, C. E. Polymeric microporous film coated subcutaneous implant. US Patent 6,022,554, 2000.
51. Guney, O.; Akgerman, A. Synthesis of Controlled-Release Products in Supercritical Medium. AIChE J. 2002, 48 (4), 856-866.
52. Dash, A. K.; Cudworth, G. C. Therapeutic applications of implantable drug Delivery systems. Pharmacol. Toxicol. Meth. 1998, 40, 1-12.
53. Soykan, O.; Donovan, M. G. Implantable System with Drug-Eluting Cells for On-Demand Local Drug Delivery. European Patent 1426021, 2004.
54. Hickey, T.; Kreutzer, D.; Burgess, D. J.; Moussy, F. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical Devices. J. Biomed. Mater. Res. 2003, 61 (2), 180-187.
55. S. Kiil, S.; Dam-Johansen, K. Controlled drug Delivery from swellable hydroxypropylmethylcellulose matrices: model-based analysis of observed radial front movements. J. Controlled Release 2003, 90, 1-21.
56. Leong, K. W.; Langer, R. Polymeric controlled Drug Delivery. Adv. Drug Delivery Rev. 1987, 1, 199-233.
57. Nam, K.; Watanabe, J.; Ishihara, K. Modeling of swelling and drug release behavior of spontaneously forming hydrogels composed of phospholipid polymers. Int. J. Pharm. 2004, 275, 259-269.
58. Mourgues, A.; Charmette, C.; Sanchez, J.; Marti-Mestres, G.; Gramain, P. EO/EP copolymer membranes as reservoir in a transdermal therapeutic system for caffeine Delivery. Modeling and simulation. J. Membr. Sci. 2004, 241, 297-304.
59. Sobol, E. N. Kinetics of Diffusion of Organometallic Compounds into Polymers from Solutions in Supercritical Carbon Dioxide. Russ. J. Phys. Chem. 1998, 72 (1), 17-20.
60. L. Polymers in Controlled Drug Delivery in Medical Plastics and Biomaterials. November 1997.
61. Mathowitz, E. C. D.; Jacob S. J. Bioadhesive drug Delivery systems. In Encyclopaedia of Controlled Drug Delivery 1; John Wiley and Sons: New York, 1999.
62. Galan, M. A.; Del Valle, E. M.M. Chemical Engineering: Trends and Developments; John Wiley and Sons: New York, 2005.
63. Andersson, M. L.; Boissier, C.; Juppo, A. M.; Larsson, A. Incorporation of Active Substances in Carrier Matrixes. European Patent 1069890, 2002.
64. Abraham, S.; Brahim, S.; Ishihara, K.; Guiseppi-Elie, A. Moleculary engineered p(HEMA)-based hydrogels for implant biochip biocompatibility. Biomaterials 2005, 26, 4767-4778.
65. Yoshida, R.; Sakai, K.; Okano, T.; Sakurai, Y. Surface-modulated skin layers of thermal responsive hydrogels as on-off switches: II. Drug permeation. J. Biomater. Sci. Polymer Edn. 1992, 3 (3), 243-252.
66. Yoshida, R.; Sakai, K.; Okano, T.; Sakurai, Y. Sigmoidal swelling profiles for temperature-responsive poly(N-isopropylacrylamide-co-butyl methacrylate) hydrogels. J. Membr. Sci. 1994, 89, 267-277.
67. Kim, S. W. Advanced Biomaterials in Biomedical Engineering and Drug Delivery Systems; Springer: Tokyo, 1996.
68. Aminabhavi, T. M.; Kulkarni, R. V.; Kulkarni, A. R. Polymers in Drug Delivery. Polymeric Transdermal Drug Delivery Systems. Polym. News 2004, 29 (7), 214-218.
69. Puttipipatkhachorn, S.; Nunthanid, J.; Yamamoto, K.; Peck, G. E. Drug Physical State and Drug-Polymer Interaction on Drug Release from Chitosan Matrix Films. J. Controlled Release 2001, 75, 143-153.
70. Powell, M. F. Drug Delivery issues in vaccine Development. Pharm. Res. 1996, 19 (12), 1777-1785.
71. Haystead, J. New Particle Engineering Technology Improves Drug Solubility. Pharm. Technol., 2003.
72. Chandra, R.; Rustgi, R. Biodegradable Polymers. Prog. Polym. Sci. 1998, 23, 1273-1335.
73. Jain, R. A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) Devices. Biomaterials 2000, 21, 2475-2490.
74. Lemaire, V.; Belair, J.; Hildgen, P. Structural modeling of drug release from biodegradable porous matrices based on a combined diffusion/ erosion process. Int. J. Pharm. 2003, 258, 95-107.
75. Tom, J. W.; Debendetti, P. G. Formation of Bioerodible Polymeric Microspheres and Microparticles by Rapid Expansion of Supercritical Solutions. Biotechnol. Prog. 1991, 7, 403-411.
76. Zhang, M.; Yang, Z.; Chow, L. L.; Wang, C. H. Simulation of Drug Release from Biodegradable Polymeric Microspheres with Bulk and Surface Erosions. J. Pharm. Sci. 2003, 92 (10), 2040-2056.
77. Ghaderi, R.; Artursson, P.; Carrhlfolds, R. A new method for preparing biodegradable microparticles and entrapment of hydrocortisone in DL-PLG microparticles. Eur. J. Pharm. Sci. 2000, 10, 1-9.
78. Colthrust, M. J.; Williams, R. L.; Hiscott, P. S.; Grierson, I. Biomaterials used in the posterior segment of the eye. Biomaterials 2000, 21, 649-665.
79. Davis, S. S. Drug Delivery Systems. Interdis. Sci. Rev. 2000, 25 (3), 175-195.
80. Angelova, N.; Hunkeler, D. Rationalizing the design of polymeric biomaterials. Trends Biotechnol. 1999, 17, 409-415.
81. Langer, R. Transdermal drug Delivery: past progress, current status, and future prospects. Adv. Drug Delivery Rev. 2004, 56, 557-558.
82. Ikada, Y. Surface modification of polymers for medical applications. Biomaterials 1994, 15 (10), 725-736.
83. Rokkaben, P. U. Absorbable Materials in Orthopaedic Surgery. Ann. Med. 1991, 23, 109-115.
84. Bures, P.; Huang, Y.; Oral, E.; Peppas, N. A. Surface Modifications and Molecular Imprinting of Polymers in Medical and Pharmaceutical Applications. J. Controlled Release 2001, 72, 25-33.
85. Debenedetti, P. G.; Tom, J. W.; Sang-Do, Y.; Gio-Bin, L. Application of supercritical fluids for the production of sustained Delivery Devices. J. Controlled Release 1993, 24, 27-31.
86. Gelinck, G. H.; Geuns, T. C. T.; de Leeuw, D. M. High-performance all-polymer integrated circuits. Appl. Phys. Lett. 2000, 77, 1487-1489.
87. Feng, J.; Dong, L. Modification of Isotactic Polypropylene Films by Grafting Methyl Acrylate Using Supercritical CO2 as a Swelling Agent. J. Supercrit. Fluids 2004, 31, 67-74.
88. Chernyak, Y.; Henon, F.; Harris, R. B.; Gould, R. D.; Franklin, R. K.; Edwards, J. R.; DeSimone, J. M.; Carbonell, R. G. Formation of perfluoropolyether coatings by rapid expansion of supercritical solutions (REES) process. 1. Experimental results. Ind. Eng. Chem. Res. 2001, 40, 6118-6126.
89. Wise, D. L. Handbook of pharmaceutical controlled release technology; Marcel Dekker: New York, 2000.
90. Bernkop-Schnurch, A.; Clausen, A. E. Biomembrane permeability of peptides: strategies to improve their mucosal uptake. Mini Rev. Med. Chem. 2002, 2, 295-305.
91. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug Discovery and Development settings. Adv. Drug Delivery Rev. 1997, 23, 3-25.
92. Palm, K.; Stenberg, P.; Luthman, K.; Artursson, P. Pharm. Res. 1997, 14, 568-571.
93. Ajay, A.; Walters, W. P.; Murcko, M. A. Can we learn to distinghuish between "drug like" and "non drug like" molecules. J. Med. Chem. 1998, 41, 3314-3324.
94. Johnson, K. C.; Swindell, A. C. Guidance in the Setting of Drug Particle Size Specifications to Minimize Variability in Absorption. Pharm. Res. 1996, 13, 1795-1798.
95. Dressman, J. B.; Amidon, G. L.; Fleischer, D. Absorption Potential estimating the fraction absorbed for orally administered compounds. J. Pharm. Sci. 1985, 74, 588-589.
96. Bakatselou, V.; Oppenheim, R. C.; Dressman, J. B. Solubilization and wetting effects of bile salts on the dissolution of steroids. Pharm. Res. 1991, 8, 1461-1469.
97. D. Horter, D.; Dressman, J. B. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. AdV. Drug Del. Rev. 1997, 25, 3-14.
98. Hite, M.; Turner, S.; Federici, C. Oral Delivery of Poorly Soluble Drugs, Part 2: Formulation Strategies for Solid Dosage Forms and Novel Delivery Systems for Controlled Release. Pharm. Manuf. Packing Source, 2003.
99. Wiedmann, T. S.; Kamel, L. Examination of the solubilization of drugs by bile salt micelles. J. Pharm. Sci. 2002, 91, 743-1764.
100. Lahana, R. How many leads from HTS. Drug Discovery Today 1999, 4, 447-448.
101. Tanford, C. The hydrophobic effect: formation of micelles and biological membranes; John Wiley & Sons: New York, 1973.
102. Charman, W. N.; Stella V. J. Lymphatic transport of drugs; CRC Press: Boca Raton, 1996.
103. Sayani, A. P.; Chien, Y. W. Systemic Delivery of peptides and proteins across absorptive mucosae. Crit. Rev. Ther. Drug Carrier Syst. 1996, 131, 85-184.